A clinical case of long-term differential diagnosis of a disseminated process in the lungs as a manifestation of mixed connective tissue disease
Connective tissue diseases (CTD) are common causes of disseminated small – focal lung damage. The complexity of diagnostic approach in such cases occur due to intolerance of many symptoms and syndromes, that can also relate to diseases of other different etiologies. It is often not possible to identify the pathognomonic syndrome in CTD, as well as to establish an accurate diagnosis after a long time. This complicates the selection of effective treatment and, accordingly, the inability to predict the course and development of the disease. Sometimes, due to the intersection of symptoms, the diagnosis sounds like «MCTD» (mixed connective tissue diseases) – a rare systemic connective tissue disease, characterized by a combination of individual signs of systemic lupus erythematosus, systemic scleroderma, rheumatoid arthritis, polymyositis. This publication presents a clinical case of a long-term course of mixed MCTD in a patient who has been observed for more than 10 years in different hospitals, and by outpatient observation, and within this year’s differential diagnosis with other CTD and infectious diseases was held, including rheumatic fever.
Solovyeva E.N., Kalyuta T.Y., Kazhekin O.A., Glukhova N.A., Rizhova G.V., Volodko L.F. 2020. A clinical case of long-term differential diagnosis of a disseminated process in the lungs as a manifestation of mixed connective tissue disease. Challenges in Modern Medicine, 43 (4): 509–521 (in Russian). DOI: 10.18413/2687-0940-2020-43-4-509-521
While nobody left any comments to this publication.
You can be first.
Volkov A.V., Martynjuk T.V. Rekomendacii po lecheniju legochnoj arterial'noj gipertenzii, associirovannoj s sistemnymi revmaticheskimi zabolevanijami [Recommendations for the treatment of pulmonary arterial hypertension associated with systemic rheumatic diseases]. Po porucheniju gruppy jekspertov ARR i VNOK //RHEUMATOLG.RU/files/natres. 2013. 10 c. (in Russian).
Shajahmetova R.U., Anan'eva L.P. 2019. Smeshannoe zabolevanie soedinitel'noj tkani [Mixed connective tissue disease]. Sovremennaja revmatologija. 13 (1): 11–18. https://doi.org/10.14412/1996-7012-2019-1-11-18 (in Russian).
Shmelev E.I. 2001. Differencial'naja diagnostika disseminirovannyh zabolevanij legkih neopuholevoj prirody [Differential diagnosis of disseminated lung diseases of non-tumor nature]. Russkij medicinskij zhurnal. 21: 919–925. URL: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Differencialynaya_diagnostika_disseminirovannyh_zabolevaniy_legkih_neopuholevoy_prirody/ixzz6hd2Rpac3 (in Russian).
Aringer M., Steiner G., Smolen J.S. 2005. Does mixed connective tissue disease exist? Yes. Rheum. Dis. Clin. North. Am. 31 (3): 411–420.
Swanton J., Isenberg D. 2005. Mixed connective tissue disease: still crazy after all these years. Rheum. Dis. Clin. North. Am. 31 (3): 421–436.
Gunnarsson R., Hetlevik S.O., Lilleby V., Molberg Ø. 2016. Mixed connective tissue disease. Best Pract. Res. Clin. Rheumatol. 30 (1): 95–111. doi: 10.1016/j.berh.2016.03.002. Epub 2016 Apr 12.
Ciang N.C., Pereira N., Isenberg D.A. 2017. Mixed connective tissue disease – enigma variations? Rheumatology (Oxford). 56 (3): 326–333. doi: 10.1093/rheumatology/ kew265.
Hajas A., Szodoray P., Nakken B., Gaal J., Zöld E., Laczik R., Demeter N., Nagy G., Szekanecz Z., Zeher M., Szegedi G., Bodolay E. 2013. Clinical course, prognosis, and causes of death in mixed connective tissue disease. J. Rheumatol. 40 (7): 1134–42. doi: 10.3899/jrheum.121272. Epub 2013 May 1.
Sharp G.C. 1987. Diagnostic criteria for classification of of MCTD. In: Kasukawa R., Sharp G.C., editors. Mixed connective tissue diseases and antinuclear antibodies. Amsterdam: Elsevier. P. 23–32.
Alarcon-Segovia D., Villareal M. 1987. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R., Sharp G.C., editors. Mixed connective tissue disease and antinuclear antibodies. Amsterdam: Elsevier. P. 33–40.
Kahn M.F., Appelboom T. Syndrom de Sharp. In: Kahn M.F., Peltier A.P., Meyer O., Piette J.C. 1991. Les maladies systemiques. 3rd Ed. Paris: Flammarion. P. 545–556.
Kasukawa R., Tojo T., Miyawaki S. 1987. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R., Sharp G., editors. Mixed connective tissue disease and antinuclear antibodies. Amsterdam: Elsevier. P. 41–47.
Cappelli S., Bellando Randone S., Martinović D., Tamas M.M., Pasalić K., Allanore Y., Mosca M., Talarico R., Opris D., Kiss C.G., Tausche A.K., Cardarelli S., Riccieri V., Koneva O., Cuomo G., Becker M.O., Sulli A., Guiducci S., Radić M., Bombardieri S., Aringer M., Cozzi F., Valesini G., Ananyeva L., Valentini G., Riemekasten G., Cutolo M., Ionescu R., Czirják L., Damjanov N., Rednic S., Matucci Cerinic M. 2012. «To Be or Not To Be», Ten Years After: Evidence for Mixed Connective Tissue Disease as a Distinct Entity. Semin. Arthritis Rheum. 41 (4): 589–598. doi: 10.1016/j.semarthrit.2011.07.010. Epub 2011 Sep 29.
Ortega-Hernandez O.D., Shoenfeld Y. 2012. Mixed connective tissue disease: An overview of clinical manifestation, diagnosis and treatment. Best Pract. Res. Clin. Rheumatol. 26 (1): 61–72. doi: 10.1016/j.berh.2012.01.009.
Sen S., Sinhamahapatra P., Choudhury S., Gangopadhyay A., Bala S., Sircar G., Chatterjee G., Ghosh A. 2014. Cutaneous manifestations of mixed connective tissue disease: study from a tertiary care hospital in eastern India. Indian J. Dermatol. 59 (1): 35–40. doi: 10.4103/ 0019-5154.123491.
Reiseter S., Gunnarsson R., Corander J., Haydon J., Lund M.B., Aaløkken T.M., Taraldsrud E., Hetlevik S.O., Molberg Ø. 2017. Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study. Arthritis Res. Ther. 19 (1): 284. doi: 10.1186/s13075-017-1494-7.
Carpintero M.F., Martinez L., Fernandez I., Romero A.C., Mejia C., Zang Y.J., Hoffman R.W., Greidinger E.L. 2015. Diagnosis and risk stratification in patients with anti-RNP autoimmunity. Lupus. 24 (10): 1057–1066. doi: 10.1177/ 0961203315575586.
Niklas K., Niklas A., Mularek-Kubzdela T., Puszczewicz M. 2018. Prevalence of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease. Medicine (Baltimore). 97 (28): e11437. doi: 10.1097/MD.0000000000011437.
Ungprasert P., Crowson C.S., Chowdhary V.R., Ernste F.C., Moder K.G., Matteson E.L. 2016. Epidemiology of mixed connective tissue disease, 1985–2014: a population-based study. Arthritis Care Res. (Hoboken). 68 (12): 1843–1848. doi: 10.1002/acr.22872. Epub 2016 Oct 1.
Burdt M.A., Hoffman R.W., Deutscher S.L., Wang G.S., Johnson J.C., Sharp G.C. 1999. Long-term outcome in mixed connective tissue disease. Arthritis Rheum. 42 (5): 899–909.
Arroyo-Avila M., Vila L.M. 2015. Cardiac tamponade in a patient with mixed connective tissue disease. J. Clin. Rheumatol. 21 (1): 42–45. doi: 10.1097/RHU.000000 0000000209.
Nica A.E., Alexa L.M., Ionescu A.O., Andronic O., Păduraru D.N. 2016. Esophageal disorders in mixed connective tissue diseases. J. Med. Life. Apr-Jun; 9 (2): 141–143.
Nascimento I.S., Bonfá E., de Carvalho J.F., Saad C.G., Vendramini M.B., Teixeira M.J., Nóbrega J.C., Viana V.S. 2010. Clues for previously undiagnosed connective tissue disease in patients with trigeminal neuralgia. J. Clin. Rheumatol. 16 (5): 205–8. doi: 10.1097/RHU.0b013e3181e928e6.